pentobarbital will minimize the extent or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

Pentobarbital also functions by inhibiting glutamate, which is chargeable for nerve depolarization while in the voltage-activated calcium currents.

pentobarbital will reduce the level or result of quetiapine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will minimize the extent or effect of paclitaxel protein bound by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.

pentobarbital will lower the level or effect of solifenacin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

Hypnotic doses of these barbiturates tend not to look to substantially impair uterine activity throughout labor; full anesthetic doses of barbiturates lessen the force and frequency of uterine contractions; administration of sedative-hypnotic barbiturates on the mother for the duration of labor may perhaps cause respiratory depression inside the new child

pentobarbital will lower the level or impact click here of vincristine liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.

pentobarbital will reduce the extent or influence of etravirine by impacting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Check.

pentobarbital will minimize the extent or impact of carvedilol by affecting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Check.

pentobarbital will lessen the level or outcome of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.

pentobarbital will decrease the level or effect of fedratinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Outcome of coadministering a robust CYP3A4 inducer with fedratinib hasn't been analyzed.

pentobarbital will lessen the level or outcome of efavirenz by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.

Contraindicated (1)pentobarbital will lessen the level or influence of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a sensitive CYP3A4 substrate. Coadministration with potent or reasonable CYP3A4 inducers is contraindicated.

pentobarbital will decrease the level or outcome of irinotecan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.